|
31 |
Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma
Enthalten in Journal of clinical immunology Bd. 39, 24.1.2019, Nr. 1, date:1.2019: 112-117
|
|
|
|
32 |
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)
Enthalten in Journal of clinical immunology Bd. 43, 27.2.2023, Nr. 5, date:7.2023: 965-978
|
|
|
|
33 |
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
Enthalten in Pediatric rheumatology Bd. 17, 8.7.2019, Nr. 1, date:12.2019: 1-9
|
|
|
|
34 |
Severe Extrahematopoietic Manifestations in Complete STAT1 LOF after Successful Allogeneic HCT
Enthalten in Journal of clinical immunology Bd. 44, 4.9.2024, Nr. 8, date:11.2024: 1-4
|
|
|
|
35 |
T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency
Enthalten in Journal of clinical immunology Bd. 40, 21.1.2020, Nr. 3, date:4.2020: 421-434
|
|
|
|
36 |
The GAIN Registry — a New Prospective Study for Patients with Multi-organ Autoimmunity and Autoinflammation
Enthalten in Journal of clinical immunology Bd. 43, 21.4.2023, Nr. 6, date:8.2023: 1289-1301
|
|
|
|
37 |
Transition for adolescents with a rare disease: results of a nationwide German project
Enthalten in Orphanet journal of rare diseases Bd. 18, 25.4.2023, Nr. 1, date:12.2023: 1-9
|
|
Administration
